Tokyo
Japan
National Institute of Infectious Diseases - AIDS Research Center
COVID-19, vaccine, CD8+ T cell, viral vector, variant
HIV, SIV, neutralizing antibody, B cells, MHC, CD8+ T cells, Nef, Akt